Phar Vision Advisers, LLC Eton Pharmaceuticals, Inc. Transaction History
Phar Vision Advisers, LLC
- $178 Billion
- Q3 2025
A detailed history of Phar Vision Advisers, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 10,535 shares of ETON stock, worth $178,041. This represents 0.13% of its overall portfolio holdings.
Number of Shares
10,535Holding current value
$178,041% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
103Shares Held
15.9MCall Options Held
103KPut Options Held
0-
Opaleye Management Inc. Boston, MA2.86MShares$48.3 Million10.4% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$34.3 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$19.9 Million1.04% of portfolio
-
Morgan Stanley New York, NY586KShares$9.9 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $428M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...